177 related articles for article (PubMed ID: 37057215)
21. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
[TBL] [Abstract][Full Text] [Related]
22. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?
Bahceci M; Tuzcu A; Bahceci S; Tuzcu S
J Endocrinol Invest; 2003 Jul; 26(7):655-9. PubMed ID: 14594118
[TBL] [Abstract][Full Text] [Related]
23. [Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?].
Robin G; Catteau-Jonard S; Young J; Dewailly D
Gynecol Obstet Fertil; 2011 Mar; 39(3):141-5. PubMed ID: 21388855
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic evaluation of hyperprolactinemia.
Biller BM
J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
[TBL] [Abstract][Full Text] [Related]
25. Frequency of Macroprolactin in Hyperprolactinemia.
Sherazi NA; Baig MZ; Khan AH
J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
[TBL] [Abstract][Full Text] [Related]
26. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
[TBL] [Abstract][Full Text] [Related]
27. True hyperprolactinemia in men without visible pituitary adenoma.
Shimon I; Rudman Y; Manisterski Y; Gorshtein A; Masri H; Duskin-Bitan H
Endocrine; 2021 Jun; 72(3):809-813. PubMed ID: 33566310
[TBL] [Abstract][Full Text] [Related]
28. Hyperprolactinemia after laparoscopic ovarian drilling: an unknown phenomenon.
Parsanezhad ME; Alborzi S; Zolghadri J; Parsa-Nezhad M; Keshavarzi G; Omrani GR; Schmidt EH
Reprod Biol Endocrinol; 2005 Aug; 3():31. PubMed ID: 16083511
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
[TBL] [Abstract][Full Text] [Related]
30. [Hyperprolactinemia].
König MP; Kopp P
Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else.
Cho A; Vila G; Marik W; Klotz S; Wolfsberger S; Micko A
Front Endocrinol (Lausanne); 2022; 13():901385. PubMed ID: 36147567
[TBL] [Abstract][Full Text] [Related]
32. The detection of macroprolactin by precipitation and ultrafiltration methods.
Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
[TBL] [Abstract][Full Text] [Related]
33. [Effect of hyperprolactinemia upon clinical symptoms of patients with polycystic ovary syndrome].
Wang Y; Hu ZP; Li MZ; Li R; Wang LN; Chen XN; Yang CS; Qiao J
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2599-603. PubMed ID: 20137674
[TBL] [Abstract][Full Text] [Related]
34. [Hyperprolactinemia in patients with non-functioning adenoma: analysis of 85 patients treated by transsphenoidal operation].
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Oku Y; Onishi T; Uozumi T
No Shinkei Geka; 1987 Nov; 15(11):1175-9. PubMed ID: 3437926
[TBL] [Abstract][Full Text] [Related]
35. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI
Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
37. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
38. SHORT-TERM DECLINE IN PROLACTIN CONCENTRATIONS CAN PREDICT FUTURE PROLACTIN NORMALIZATION, TUMOR SHRINKAGE, AND TIME TO REMISSION IN MEN WITH MACROPROLACTINOMAS.
Tirosh A; Benbassat C; Shimon I
Endocr Pract; 2015 Nov; 21(11):1240-7. PubMed ID: 26247115
[TBL] [Abstract][Full Text] [Related]
39. Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia?
Varaldo E; Cuboni D; Prencipe N; Aversa LS; Sibilla M; Bioletto F; Berton AM; Gasco V; Ghigo E; Grottoli S
Endocrine; 2024 May; 84(2):670-676. PubMed ID: 38194218
[TBL] [Abstract][Full Text] [Related]
40. Hyperprolactinemia and associated pituitary prolactinomas.
Brenner SH; Lessing JB; Quagliarello J; Weiss G
Obstet Gynecol; 1985 May; 65(5):661-4. PubMed ID: 4039046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]